Search
for

    Sort by

    Research 931–960 of 1000+

    1. 61346 Baseline Psychosocial Impact of Disease in Patients with Severe Alopecia Areata Treated with Baricitinib Recruited from the US Customer Support Program Journal of the American Academy of Dermatology · 2025
    2. Effectiveness of Generic Tofacitinib in the Treatment of Patients with Mild Alopecia Areata in China: A Retrospective Real-World Study Journal of Cutaneous Medicine and Surgery · 2024
    3. Baricitinib Therapy for Moderate to Severe Alopecia Areata: A Retrospective Review of 95 Japanese Patients Acta dermato-venereologica · 2024
    4. 63407 A Descriptive Analysis of Patients With Moderate-to-Severe Atopic Dermatitis and Comorbid Alopecia Areata in the Abrocitinib JADE Clinical Program Journal of the American Academy of Dermatology · 2025
    5. 125: Individual Severity of Alopecia Tool (SALT) score trajectories of roll-over adolescent patients with alopecia areata (AA) treated with ritlecitinib in the ongoing long-term, open-label, phase 3 ALLEGRO-LT study Journal of Investigative Dermatology · 2025
    6. Risk Factors for the Development of and Outcomes After Diagnosis of Autoimmune Alopecia Areata in Patients with Inflammatory Bowel Diseases Digestive Diseases and Sciences · 2024 · 2 citations
    7. Photographic assessment improves adherence to recommended follow-up in patients with androgenetic alopecia and alopecia areata: A retrospective cohort study Indian Journal of Dermatology, Venereology and Leprology · 2019 · 1 citations
    8. Assessment of serum 25-hydroxyvitamin D levels in patients with extensive/recalcitrant alopecia areata before and after PUVA and NB-UVB therapy Journal of the Egyptian Womenʼs Dermatologic Society · 2015 · 3 citations
    9. 73192 Consistent Efficacy of Upadacitinib in Alopecia Areata Subgroups: Adult, Pediatric, Severe Disease, and JAK-Refractory Patients — A Meta-Analysis Journal of the American Academy of Dermatology · 2026
    10. 74643 Deuruxolitinib improves scalp hair regrowth over time in patients with severe alopecia areata: Pooled analysis of the THRIVE-AA1 and THRIVE-AA2 Phase 3 trials Journal of the American Academy of Dermatology · 2026
    11. Comparing the efficacy of oral apremilast, intralesional corticosteroids, and their combination in patients with patchy alopecia areata: a randomized clinical controlled trial Archives of Dermatological Research · 2024 · 4 citations
    12. [Translated article] Allergic Contact Dermatitis Due to Minoxidil in a Patient With Alopecia Areata Actas Dermo-Sifiliográficas · 2022
    13. Multivariate analysis of clinical characteristics and prognostic factors in early-onset alopecia areata: a retrospective study with 82 Brazilian patients Anais Brasileiros de Dermatologia · 2023 · 2 citations
    14. Eyebrows and Eyelashes Regrowth Across Different SALT Response Thresholds in Patients with Alopecia Areata: Outcomes from the BRAVE AA Clinical Program SKIN The Journal of Cutaneous Medicine · 2023 · 1 citations
    15. 74582 Early improvement in scalp hair regrowth with deuruxolitinib in patients with severe alopecia areata: Pooled analysis of the THRIVE-AA1 and THRIVE-AA2 Phase 3 trials Journal of the American Academy of Dermatology · 2026
    16. 1565 nm laser and topical drugs for hair regeneration in patients with alopecia areata Asian Journal of Surgery · 2025
    17. Functional analyses of the stratum corneum of scalp skin : Studies in patients with alopecia areata and androgenetic alopecia 2001
    18. PCR30 PSYCHOMETRIC EVALUATION OF SKINDEX-16 AA, THE ALOPECIA AREATA SYMPTOM IMPACT SCALE (AASIS), AND THE SCALP HAIR ASSESSMENT PATIENT-REPORTED OUTCOME (PRO) IN ADULTS AND ADOLESCENTS WITH SEVERE ALOPECIA AREATA Value in Health · 2026
    19. Publisher Correction: Improvement in Measures of Quality of Life and Symptoms of Anxiety and Depression in Patients with Severe Alopecia Areata Achieving Sustained Scalp Hair Regrowth with Baricitinib Dermatology and Therapy · 2024
    20. 50392 Impact of Baseline Psychiatric and Autoimmune Comorbidities on Economic Burden for Patients in the United States in the First Year After Diagnosis with Alopecia Areata Journal of the American Academy of Dermatology · 2024
    21. Assessment of Zinc and Copper Contents in Scalp Hair and Serum and Superoxide Dismutase, Glutathione Peroxidase and Malondialdehyde in Serum of Androgenetic Alopecia and Alopecia Areata Patients Medical journal of Tabriz University of Medical Sciences and Health Services · 2011 · 4 citations
    22. 75810 Long-term efficacy, complete scalp hair regrowth, and normal body hair and nails in patients with alopecia areata (AA) receiving ritlecitinib 50 mg once daily up to 3 years in the ALLEGRO clinical trial program Journal of the American Academy of Dermatology · 2026
    23. Alopecia in patients with COVID-19: A systematic review and meta-analysis JAAD International · 2022 · 25 citations
    24. Childhood Alopecia: Patent and Treatment Method 2026
    25. IMPACTOS CAPILARES DA COVID-19 A LIGAÇÃO ENTRE EFLÚVIO TELÓGENO AGUDO E ALOPECIA AREATA: REVISÃO INTEGRATIVA Recima21 · 2024
    26. Permanent alopecia in patients with breast cancer after taxane chemotherapy and adjuvant hormonal therapy: Clinicopathologic findings in a cohort of 10 patients Journal of The American Academy of Dermatology · 2017 · 31 citations
    27. Dermoscopic findings of alopecia areata in dark skinned individuals: An analysis of 116 cases International Journal of Trichology · 2014 · 21 citations
    28. Current and future treatments of alopecia areata and trichotillomania in children Expert opinion on pharmacotherapy · 2016 · 8 citations
    29. Trichoscopic findings in patients with patchy alopecia and its comparison with histopathological diagnosis Muller Journal of Medical Sciences and Research · 2024
    30. Cardiovascular risk in patients with scarring and nonscarring alopecias: Assessing the current state of evidence JEADV Clinical Practice · 2023